PHARMA
Trending stocks: Lupin shares gain nearly 1%A total of 15,727 shares changed hands on the counter till 09:36AM.
- Share market update: Nifty Pharma index flat; Cadila Healthcare up 1%
The Nifty Pharma index was trading 0.41 per cent up at 11363.65.
- Why Vaibhav Sanghavi is extremely bearish on the market
Before the market consolidates and moves up further, we will need to have a healthy correction. That is where we think the market is probab...
- Lock some gains and keep 10-15% cash in your portfolio: Dipan Mehta
At least some amount of cash should be left in the portfolio and you could trim your portfolios in stocks which have run up and are trading...
- Centre plans on tweaking drug policy that exempts foreign medicines from price control
The government broadened the five-year exemption from price control for new foreign drugs patented in India through an amendment in January...
- Time to ride growth and momentum, go for IT and pharma: Ajay Bagga
It is better to play external focussed sectors and within that, growth stocks are the best place to be in at least for the next three to fo...
- Long-term investors, start taking profits now: Anand Tandon
It is time to move out because there is no real value in most of the banking stocks and even Reliance.
- Over next 3-5 years, we are in for a decent pickup in automobile cycle: Pramod Gubbi
We will have to wait and see how soon we can get around the whole Covid situation.
- BDR Pharmaceuticals launches Favipiravir under brand name 'BDFAVI' at Rs 63 per tablet in India
BDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...
- Nearly 35-40% of our weightage is in pharma, that story has just begun: Ravi Dharamshi
'I cannot rule out a correction or a dip at any point of time but you need to be looking to buy.'
- IHH to continue to execute Fortis plan: Koji Nagatomi, India Chairperson Mitsui
IHH Healthcare Berhad’s acquisition of Fortis Healthcare has been caught in a logjam since December 2018 after the Supreme Court put the sa...
- Why should moratorium end? Healthy companies using it to conserve cash
An analysis on over 300 companies having a total debt of Rs 4 lakh crore shows that at least 40% of the loans under moratorium are in secto...
- Centre looking to hike import duty on bulk drugs, in bid to boost local manufacturing
The department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts for...
- Q1 net more than annual profit! This API maker is creating a splash on Dalal Street
APIs are active pharma ingredients used to make drugs, while formulation is the process where APIs are used in specific ratios to produce a...
- Stock pick of the week: Recent dip in Abbott India price offers entry point to long-term investors
Abbott India is expected to end 2020-21 with revenue and net profit growth of 11% and 18% respectively. Besides, its debt-free status along...
- Stocks in the news: Axis Bank, Vodafone Idea, Sun Pharma, Adani Ports, Cipla, SBI Card
Axis Bank has launched its qualified institutional placement (QIP) on Tuesday to raise up to Rs 10,000 crore.
- Will continue to focus on growing businesses faster than market: Sun Pharma
Drug major Sun Pharma will remain focussed on growing its businesses faster than the market in which it operates, the company said in its A...
- View: India needs to alter its 'patent box' regime as it aims for Atmanirbharta
While India’s patent box provisions are rightly aligned with Organisation for Economic Cooperation and Development (OECD) recommendations, ...
- Sun Pharma Q1 preview: Net profit may drop up to 35%; flat sales likely on high base
Centrum Broking expects the drug maker to report 1.8 per cent decline in net sales at Rs 8,110 crore compared with Rs 8,259 crore in the sa...
MORE NEWS
